VIM and breast carcinoma: We then examined the effects of Trametinib on the highly ordered subcellular organization of vimentin in various cell types, including A549 lung epithelial cells, L929 mouse fibroblasts, THP-1 macrophages, and MDA-231 breast cancer cells.